Bioventus BVS
NASDAQ BVS
$14.33 -0.35 (-2.38%)
At close: Aug 20, 2026 · 4:00 PM EDT

Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2026)

Bioventus' (BVS) quarterly Income from Non-Controlling Interests came in at $744000.0 in Q1 2026, up 208.61% YoY from $241078.5 in Q1 2025, and up 137.59% on a QoQ basis from -$2.0 million in Q4 2025.

Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Bioventus (BVS) has 7 years of Income from Non-Controlling Interests data on file, last reported at $744000.0 in Q1 2026.

  • Quarterly Income from Non-Controlling Interests rose 208.61% year-over-year to $744000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 41.2% YoY) and the FY2023 annual result came in at -$24.5 million, down 75.26% from the prior year.
  • Income from Non-Controlling Interests advanced to $744000.0 in Q1 2026, from -$2.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $10.7 million in Q4 2024 to a low of -$14.9 million in Q2 2023.
  • A 5-year average of -$2.4 million and a median of -$1.5 million in 2023 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests slumped 764.95% — and 2024, when it soared 786.47%.
  • Tracing BVS's Income from Non-Controlling Interests over 5 years: stood at -$4.7 million in 2022, then surged by 66.84% to -$1.6 million in 2023, then jumped by 786.47% to $10.7 million in 2024, then slumped by 118.48% to -$2.0 million in 2025, then surged by 137.59% to $744000.0 in 2026.
  • The last three Income from Non-Controlling Interests figures came in at $744000.0 (Q1 2026), -$2.0 million (Q4 2025), and $601000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -2.00 Mn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -500,000.00
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 13.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 2.32 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 900,000.00
10 Bioventus 972.56 Mn 943.11 Mn 105.67 Mn 2.98 Mn

Historic Data

Download Data
DateValue
Jun 27, 2026 2.98 Mn
Mar 28, 2026 744,000.00
Dec 31, 2025 -1.98 Mn
Sep 27, 2025 601,000.00
Jun 28, 2025 1.81 Mn
Mar 29, 2025 -685,000.00
Dec 31, 2024 10.71 Mn
Sep 28, 2024 -570,000.00
Jun 29, 2024 -8.62 Mn
Mar 30, 2024 -1.49 Mn
Dec 31, 2023 -1.56 Mn
Apr 1, 2023 -14.94 Mn
Dec 31, 2022 -4.70 Mn
Oct 1, 2022 -9.25 Mn
Apr 2, 2022 -3.53 Mn
Dec 31, 2021 8.26 Mn
Oct 2, 2021 -1.30 Mn
Jul 3, 2021 -6.65 Mn
Apr 3, 2021 -408,000.00
Dec 31, 2020 -525,000.00